Form D · Pharmaceuticals
BiomX Inc.
Ness Ziona, L3 · CIK 0001739174
Offering snapshot reported Jan 20, 2026 · SEC filing
- Reported sold
- $3.3M Offering amount: $3.3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 20, 2026 | Initial | $3,300,000 | No comparison | 1 | SEC filing |
| Apr 1, 2024 | Initial | $61,547,439 | No comparison | 34 | SEC filing |
| Mar 3, 2023 | Initial | $1,461,324 | No comparison | 10 | SEC filing |
| Jan 4, 2022 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Oct 25, 2021 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $210K
- Finders' fees
- $0
- Form D file number
- 021-570448
On January 13, 2026, the Company issued and sold 3,300 shares of Series Y Convertible Preferred Stock and warrants to purchase common stock. The Total Offering Amount excludes proceeds from any conversion of the preferred stock or exercise of the warrants
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 000000375 |
Source: Form D, filed Jan 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gbola Amusa | Director |
| Merav Bassan | Executive |
| Susan Blum | Director |
| Avi Gabay | Executive |
| Jesse Goodman | Director |
| Russell Greig | Director |
| Jonas Grossman | Director |
| Jonathan Leff | Director |
| Gregory Merril | Director |
| Alan Moses | Director |
| Assaf Oron | Executive |
| Sailaja Puttagunta | Executive |
| Paul Sekhri | Director |
| Jonathan Solomon | Director, Executive |
| Lynne Sullivan | Director |
| Eddie Williams | Director |
| Edward Williams | Director |
| Marina Wolfson | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
22 Einstein Street, Floor 4
Ness Ziona, L3, 7414003
Phone: +972 723942377
Ness Ziona, L3, 7414003
Phone: +972 723942377